The small G protein Rap 1 in T cell activation/anergy
T 细胞激活/无反应中的小 G 蛋白 Rap 1
基本信息
- 批准号:6511270
- 负责人:
- 金额:$ 30.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-03-15 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:CD28 molecule CD3 molecule T cell receptor T lymphocyte anergy genetically modified animals guanine nucleotide binding protein guanosinetriphosphatases interleukin 2 laboratory mouse leukocyte activation /transformation mitogen activated protein kinase protein biosynthesis tissue /cell culture transfection
项目摘要
DESCRIPTION (Provided by the Applicant): A productive T lymphocyte response to
antigen requires the activation of two signaling pathways, involving signals
generated by the interactions between the T-cell receptor (TCR) with antigenic
peptide presented on antigen-presenting cells (APCs) and the signal mediated by
the binding of the accessory receptor CD28 with its ligand B7. Although the
requirement for CD28 co-stimulation has been the subject of intensive and
extensive investigation, the molecular nature of this co-stimulatory signal is
unknown. Some models have identified distinct kinase cascades initiated by
either the ICR or CD28, while other models have focused on the convergence of
TCR/CD28 signals on particular kinase cascades. One pathway which can mediate
the synergistic responses that characterize CD28 co-stimulation is the MAP
kinase (ERK) cascade. The activation of the MAP kinase ERK following CD28
co-stimulation is required for IL-2 production and proliferation of responding
T lymphocytes. ERK activation in T lymphocytes is regulated by two antagonistic
small G proteins: Ras and Rap1. Ras activation is required for ERK activation,
while Rap1 antagonizes Ras signaling. Antigen recognition by T-cells in the
absence of CD28 co-stimulation is characterized by impaired ERK activation and
both decreased IL-2 production and diminished proliferation. This functional
unresponsiveness results in the inability to respond to subsequent
co-stimulatory signals and is termed clonal anergy. Rap1 is constitutively
activated in certain states of I cell anergy or this unresponsiveness may
account for the diminished ERK activity and decreased IL-2 production seen in
anergic T-cells. In this proposal, we will test the hypothesis that Rap1 is
activated by ICR ligation in normal I cells and consequently limits I cell
activation through the ICR in the absence of co-stimulation. In addition, we
will test the hypothesis that CD28 co-stimulation achieves increased ERK
activation, IL-2 production and proliferation by blocking Rap1 activation.
描述(由申请人提供):一种生产性T淋巴细胞反应
抗原需要激活两条信号通路,涉及信号
由T细胞受体(TCR)与抗原相互作用产生
抗原提呈细胞上递呈的多肽及其介导的信号转导
辅助受体CD28与其配体B7的结合。尽管
CD28共刺激的要求一直是密集和
经过广泛的研究,这种共刺激信号的分子性质是
未知。一些模型已经确定了不同的激酶级联反应由
ICR或CD28,而其他模型则专注于
特定激酶上的TCR/CD28信号级联。一条可以调解的途径
CD28共刺激的协同反应的特征是MAP
激酶(ERK)级联。CD28激活MAP激酶ERK的研究
IL-2的产生和反应的增殖需要共刺激
T淋巴细胞。两种拮抗剂对T淋巴细胞ERK活性的调节
小G蛋白:RAS和RAP1。ERK激活需要RAS激活,
而RAP1拮抗RAS信号。外周血中T细胞的抗原识别作用
缺乏CD28共刺激的特征是ERK激活受损和
两者都减少了IL-2的产生,抑制了细胞增殖。此功能
无响应会导致无法对后续
共刺激信号,称为克隆性无能。RAP1是结构性的
在i细胞无能的某些状态下被激活,或者这种无反应可能
导致ERK活性降低和IL-2产生减少的原因
无能T细胞。在这个提案中,我们将测试RAP1是
由ICR连接激活的正常I细胞,从而限制I细胞
在没有共刺激的情况下,通过ICR激活。此外,我们
将检验CD28共刺激实现ERK增加的假设
通过阻断Rap1的激活、IL-2的产生和增殖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP J.S. STORK其他文献
PHILIP J.S. STORK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP J.S. STORK', 18)}}的其他基金
Spatial control of cAMP signaling by Epacs
Epacs 对 cAMP 信号传导的空间控制
- 批准号:
8181877 - 财政年份:2011
- 资助金额:
$ 30.2万 - 项目类别:
Spatial control of cAMP signaling by Epacs
Epacs 对 cAMP 信号传导的空间控制
- 批准号:
8320237 - 财政年份:2011
- 资助金额:
$ 30.2万 - 项目类别:
Spatial control of cAMP signaling by Epacs
Epacs 对 cAMP 信号传导的空间控制
- 批准号:
8502657 - 财政年份:2011
- 资助金额:
$ 30.2万 - 项目类别:
Spatial control of cAMP signaling by Epacs
Epacs 对 cAMP 信号传导的空间控制
- 批准号:
8685251 - 财政年份:2011
- 资助金额:
$ 30.2万 - 项目类别:
Modulation of Intracellular Signaling in Cardiac Hypertrophy
心脏肥大中细胞内信号传导的调节
- 批准号:
7298850 - 财政年份:2007
- 资助金额:
$ 30.2万 - 项目类别:
The small G protein Rap 1 in T cell activation/anergy
T 细胞激活/无反应中的小 G 蛋白 Rap 1
- 批准号:
6632272 - 财政年份:2001
- 资助金额:
$ 30.2万 - 项目类别:
The small G protein Rap 1 in Tau cell activation/anergy
Tau 细胞激活/无反应中的小 G 蛋白 Rap 1
- 批准号:
6327005 - 财政年份:2001
- 资助金额:
$ 30.2万 - 项目类别:
The small G protein Rap 1 in T cell activation/anergy
T 细胞激活/无反应中的小 G 蛋白 Rap 1
- 批准号:
6867359 - 财政年份:2001
- 资助金额:
$ 30.2万 - 项目类别:
The small G protein Rap 1 in T cell activation/anergy
T 细胞激活/无反应中的小 G 蛋白 Rap 1
- 批准号:
6706955 - 财政年份:2001
- 资助金额:
$ 30.2万 - 项目类别:
相似海外基金
Analysis of the role of CD3 molecule expressing in germinal center B cells
生发中心B细胞表达CD3分子的作用分析
- 批准号:
26860327 - 财政年份:2014
- 资助金额:
$ 30.2万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




